サインイン

Chapter 17

Pharmacotherapy of the Epilepsies

下肢の動脈
下肢の動脈
Epilepsy is a chronic neurological disorder characterized by recurrent, unpredictable seizures. Seizures result from abnormal electrical discharges in the ...
発作:分類
発作:分類
Epilepsy is a chronic neurological disorder characterized by unpredictable seizures. Seizures can be provoked by identifiable factors or occur ...
抗てんかん薬:ナトリウムチャネル遮断薬
抗てんかん薬:ナトリウムチャネル遮断薬
Antiepileptic drugs, essential in managing epilepsy, effectively prevent seizures by blocking the movement of sodium ions through channels in the ...
抗てんかん薬:GABA作動性経路増強剤
抗てんかん薬:GABA作動性経路増強剤
γ-aminobutyric acid or GABA pathway potentiators are drugs used to manage epilepsy by enhancing GABA neurotransmission, a critical inhibitory pathway ...
抗てんかん薬:カルシウムチャネル遮断薬
抗てんかん薬:カルシウムチャネル遮断薬
Calcium channel blockers, primarily known for cardiovascular use, have also shown potential as antiepileptic drugs. They exert their effects by modulating ...
抗てんかん薬:グルタミン酸拮抗薬。
抗てんかん薬:グルタミン酸拮抗薬。
Glutamate is the primary excitatory neurotransmitter in the brain, essential for neuronal communication. It plays a crucial role in synaptic transmission, ...
抗てんかん薬:SV2Aタンパク質が媒介する神経伝達物質放出の調節因子
抗てんかん薬:SV2Aタンパク質が媒介する神経伝達物質放出の調節因子
Antiepileptic drugs, like levetiracetam and brivaracetam, leverage the synaptic vesicle protein SV2A to mitigate seizures. SV2A is a transmembrane ...
抗てんかん薬:カリウムチャネル活性化剤
抗てんかん薬:カリウムチャネル活性化剤
The Antiepileptic drug ezogabine functions as a potassium channel activator by enhancing transmembrane potassium currents mediated by the KCNQ subtype of ...
JoVE Logo

個人情報保護方針

利用規約

一般データ保護規則

研究

教育

JoVEについて

Copyright © 2023 MyJoVE Corporation. All rights reserved